Targeting prEssure-Muscle-index to Avoid Ventilatory Over-Assistance During Pressure Support Ventilation
Launched by CENTRE FOR MEDICAL SCIENCES · Apr 2, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The TEMA study is looking at how to improve breathing support for patients with serious lung issues, specifically those who are receiving mechanical ventilation due to acute hypoxemic respiratory failure (AHRF). Researchers want to understand how to set the right level of ventilatory support by using a measure called the Pressure-Muscle Index (PMI). The goal is to find a balance that helps patients breathe better without giving them too much assistance, which can lead to problems like muscle weakness in the diaphragm or lung injuries.
To participate in this study, individuals must be at least 18 years old, be in the ICU on mechanical ventilation for AHRF, and have certain blood gas measurements. They should also have an arterial line for easy blood sampling. The study is not yet recruiting participants, but it will involve carefully monitoring how changes in ventilatory support can be tailored to each patient's needs. This research could help make breathing support safer and more effective for people facing serious lung challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥ 18 years
- • 2. Mechanically ventilated in the ICU
- • 3. Diagnosis of Acute Hypoxemic Respiratory Failure (AHRF)
- • 4. Normocapnia or non-severe hypercapnia
- • 5. Receiving Pressure Support Ventilation (PSV) for at least 24-72 hours
- • 6. Presence of an arterial line for blood gas sampling
- Exclusion Criteria:
- • 1. Age \< 18 years
- • 2. Known neurological or neuromuscular disorders affecting diaphragm function
- • 3. Chronic Obstructive Pulmonary Disease (COPD) or hypercapnic respiratory failure
- • 4. Psychomotor agitation or inadequate sedation
About Centre For Medical Sciences
The Centre for Medical Sciences is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and development. Committed to enhancing patient outcomes, the Centre collaborates with a network of healthcare professionals, academic institutions, and industry partners to conduct rigorous clinical trials across various therapeutic areas. With a focus on ethical practices and regulatory compliance, the Centre strives to contribute to the scientific community by facilitating the discovery and evaluation of new treatments, thereby improving the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trento, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported